Multidrug-Resistant Tuberculosis Treatment Outcome and Associated Factors at the University of Gondar Comprehensive Specialized Hospital: A Ten-Year Retrospective Study.
Teshome BelachewSeid YaheyaNehemia TilahunEshet GebrieRim SeidTilahun NegaSirak BisetPublished in: Infection and drug resistance (2022)
This study indicated that nearly 23% of MDR/RR-TB patients had unsuccessful treatment outcomes and being older was significantly correlated with these outcomes. For better outcomes, it is recommended to strengthen combined treatment adherence interventions and evaluate treatment regimens and administration options. A prospective cohort study may be required to investigate the full range of potential causes of unfavorable outcomes.
Keyphrases
- multidrug resistant
- mycobacterium tuberculosis
- healthcare
- end stage renal disease
- newly diagnosed
- ejection fraction
- drug resistant
- palliative care
- glycemic control
- cystic fibrosis
- metabolic syndrome
- human immunodeficiency virus
- hiv aids
- combination therapy
- insulin resistance
- patient reported outcomes
- weight loss
- klebsiella pneumoniae
- community dwelling